Christensen; Ib Jarle

Patent Applications and Registrations

Patent applications and USPTO patent grants for Christensen; Ib Jarle.The latest application filed is for "ykl-40 as a marker for gastrointestinal cancers".

Company Profile

0.6.9

Christensen; Ib Jarle - Hillerod N/A DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
YKL-40 as a general marker for non-specific disease Grant 8,697,384 - Johansen , et al. April 15, 2	2014-04-15
YKL-40 as a marker for gastrointestinal cancers Grant 8,580,520 - Johansen , et al. November 12, 2	2013-11-12
Ykl-40 As A Marker For Gastrointestinal Cancers App 20120070853 - Johansen; Julia Sidenius ; et al.	2012-03-22
Ykl-40 As A Marker For Selection Of Treatment And Monitoring Of A Disease App 20120040355 - Johansen; Julia Sidenius ; et al.	2012-02-16
Methods Of Classifying The Severity Of Diseases Or Disorders App 20120040354 - Johansen; Julia Sidenius ; et al.	2012-02-16
Tissue Inhibitor Of Matrix Metalloproteinases Type-1 (timp-1) As A Cancer Marker And Postoperative Marker For Minimal Residual Disease Or Recurrent Disease In Patients With A Prior History Of Cancer App 20110294148 - Holten-Andersen; Mads Nikolaj ; et al.	2011-12-01
Tissue Inhibitor Of Matrix Metalloproteinases Type-1 (timp-1) As A Cancer Marker App 20110060529 - Holten-Andersen; Mads ; et al.	2011-03-10
Ykl-40 As A General Marker For Non-specific Disease App 20110045518 - Johansen; Julia ; et al.	2011-02-24
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker Grant 7,807,379 - Holten-Andersen , et al. October 5, 2	2010-10-05
Tissue Inhibitor Of Matrix Metalloproteinases Type-1 (timp-1) As A Cancer Marker And Postoperative Marker For Minimal Residual Disease Or Recurrent Disease In Patients With A Prior History Of Cancer App 20080261246 - Holten-Andersen; Mads Nikolaj ; et al.	2008-10-23
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer Grant 7,374,886 - Holten-Andersen , et al. May 20, 2	2008-05-20
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker App 20070020707 - Holten-Andersen; Mads ; et al.	2007-01-25
Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer App 20030082652 - Holten-Andersen, Mads Nikolaj ; et al.	2003-05-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.